docetaxel anhydrous has been researched along with Fibrosarcoma in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iwata, S; Kawai, A; Kondo, T; Noguchi, R; Ono, T; Sin, Y; Sugaya, J; Tsuchiya, R; Yoshida, A; Yoshimatsu, Y | 1 |
| Algarra, I; Chamorro, V; Collado, A; Garcia-Lora, AM; Garrido, C; Garrido, F; Romero, I | 1 |
| Boggs, JW; Choo, EF; Deng, Y; Hop, CE; McNamara, E; Messick, K; West, K | 1 |
| Agrawal, GP; Chashoo, G; Gupta, M; Gupta, PN; Saxena, AK; Sharma, PR; Vyas, SP | 1 |
| Pazos Arias, B; Peteiro Cancelo, A; Romero Reinoso, C; Samprón Rodríguez, M; Vello Román, A | 1 |
| Algarra, I; Berruguilla, E; Cancela, B; Collado, A; García-Lora, A; Garrido, C; Garrido, F; Romero, I | 1 |
| Dicker, AP; Grant, DS; Williams, TL; Zahaczewsky, M | 1 |
| Glehen, O; Mohamed, F; Stuart, OA; Sugarbaker, PH; Urano, M | 1 |
| Magee, CC; Mendez, GP; Rennke, HG; Schlondorff, JS | 1 |
| Cao, S; Harstrick, A; Rustum, YM; Seeber, S; Vanhoefer, U | 1 |
10 other study(ies) available for docetaxel anhydrous and Fibrosarcoma
| Article | Year |
|---|---|
Establishment and characterization of NCC-MFS4-C1: a novel patient-derived cell line of myxofibrosarcoma.
Topics: Aged; Antineoplastic Agents; Bortezomib; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Dactinomycin; Depsipeptides; DNA Copy Number Variations; Docetaxel; Drug Screening Assays, Antitumor; Female; Fibrosarcoma; Furans; Humans; Ketones; Neoplasm Invasiveness; Spheroids, Cellular | 2021 |
MHC Intratumoral Heterogeneity May Predict Cancer Progression and Response to Immunotherapy.
Topics: Animals; Cell Line, Tumor; Disease Models, Animal; Docetaxel; Fibrosarcoma; Histocompatibility Antigens Class I; Immunotherapy; Male; Methylcholanthrene; Mice, Inbred BALB C; Oligodeoxyribonucleotides; Polysaccharides | 2018 |
Assessment of the hepatic CYP reductase null mouse model and its potential application in drug discovery.
Topics: Animals; Antineoplastic Agents; Cytochrome P-450 Enzyme System; Docetaxel; Drug Discovery; Female; Fibrosarcoma; Hypnotics and Sedatives; Liver; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Midazolam; NADPH-Ferrihemoprotein Reductase; Taxoids; Theophylline; Vasodilator Agents | 2014 |
Dual targeted polymeric nanoparticles based on tumor endothelium and tumor cells for enhanced antitumor drug delivery.
Topics: Animals; Antineoplastic Agents; Apoptosis; CD13 Antigens; Cell Cycle; Cell Proliferation; Cells, Cultured; Docetaxel; Drug Carriers; Drug Delivery Systems; Fibrosarcoma; Flow Cytometry; Hemolysis; Human Umbilical Vein Endothelial Cells; Humans; Lactic Acid; Macrophages; Mice; Mice, Inbred BALB C; Nanoparticles; Oligopeptides; Phagocytosis; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Taxoids; Tissue Distribution | 2014 |
[Nephropathy following administration of angiogenesis inhibitors].
Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Bowman Capsule; Dacarbazine; Deoxycytidine; Disease Progression; Docetaxel; Doxorubicin; Endothelium, Vascular; Fibrosarcoma; Gemcitabine; Glomerulonephritis, Membranoproliferative; Humans; Ifosfamide; Lung Neoplasms; Male; Mesna; Muscle Neoplasms; Podocytes; Proteinuria; Taxoids; Vascular Endothelial Growth Factor A | 2011 |
Immunotherapy eradicates metastases with reversible defects in MHC class I expression.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Combined Modality Therapy; Docetaxel; Fibrosarcoma; Histocompatibility Antigens Class I; Humans; Immunotherapy; Immunotherapy, Adoptive; Lung Neoplasms; Lymphatic Metastasis; Male; Mice; Mice, Inbred BALB C; Proteoglycans; Taxoids | 2011 |
Comparison of antiangiogenic activities using paclitaxel (taxol) and docetaxel (taxotere).
Topics: Angiogenesis Inhibitors; Animals; Aorta; Apoptosis; Capillaries; Carcinoma, Non-Small-Cell Lung; Cell Differentiation; Cell Division; Cells, Cultured; Chemotaxis; Docetaxel; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Endothelium, Vascular; Fibrosarcoma; Glioblastoma; Humans; Lung Neoplasms; Male; Melanoma; Mice; Mice, Nude; Neoplasm Transplantation; Paclitaxel; Rats; Taxoids; Tumor Cells, Cultured; Umbilical Veins; Xenograft Model Antitumor Assays | 2003 |
Docetaxel and hyperthermia: factors that modify thermal enhancement.
Topics: Animals; Antineoplastic Agents, Phytogenic; Disease Models, Animal; Docetaxel; Fibrosarcoma; Hyperthermia, Induced; Injections, Intraperitoneal; Mice; Mice, Inbred C3H; Taxoids | 2004 |
Electrolyte abnormalities and progressive renal failure in a cancer patient.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Biopsy; Creatinine; Deoxycytidine; Diagnosis, Differential; Disease Progression; Docetaxel; Drug Administration Schedule; Fibrosarcoma; Follow-Up Studies; Gastrointestinal Stromal Tumors; Gemcitabine; Humans; Ifosfamide; Inflammation; Kidney; Kidney Glomerulus; Kidney Tubules; Male; Middle Aged; Renal Insufficiency; Taxoids; Treatment Outcome; Water-Electrolyte Imbalance | 2007 |
Comparative antitumor efficacy of docetaxel and paclitaxel in nude mice bearing human tumor xenografts that overexpress the multidrug resistance protein (MRP)
Topics: Animals; Antineoplastic Agents, Phytogenic; ATP-Binding Cassette Transporters; Docetaxel; Fibrosarcoma; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Paclitaxel; Sarcoma, Experimental; Taxoids; Transplantation, Heterologous; Tumor Cells, Cultured; Up-Regulation | 1997 |